Cite
HARVARD Citation
Culha, M. et al. (2016). Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy. Medical hypotheses. pp. 151-153. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Culha, M. et al. (2016). Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy. Medical hypotheses. pp. 151-153. [Online].